Literature DB >> 1747726

Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis.

D R Greene1, T M Wheeler, S Egawa, R P Weaver, P T Scardino.   

Abstract

A detailed morphometric analysis of 96 radical prostatectomy specimens (13 clinical stage A1, 29 A2, 34 B1 and 20 B2) was undertaken to examine the relationship of zone of origin to volume, grade and extraprostatic extension of cancer. In patients with stage A disease, transition zone (TZ) cancer (present in 81%) was significantly larger but of lower grade than peripheral zone (PZ) cancer (present in 90%). The total volume of cancer in stage A1 patients averaged 1.55 ml with 72% of TZ origin. In patients with stage A2 disease, tumour volume averaged 5.83 ml with only 57% of TZ origin. Specimens taken during transurethral resection of the prostate (TURP) revealed TZ cancer in 82% and PZ cancer either alone or with TZ cancer in 22%. The 9 patients with PZ cancer in the TURP specimen included 5 of the 11 with extracapsular extension and all 5 of those with seminal vesicle invasion. Every patient with stage B disease had PZ cancer which, in all except 3 cases, was of significantly larger volume and higher grade than any TZ cancer (present in 43%) in the same gland. In patients with stage B cancer, total tumour volume was 5.13 ml with 91% of PZ origin. TZ cancer tended to be well differentiated in all patients, even at large volumes, whereas PZ cancer was often moderately or poorly differentiated even at low volumes. In patients with stage B disease, TZ cancer appeared to be incidental and of no clinical importance, while in stage A patients PZ cancers were sometimes large, poorly differentiated and extended outside the prostate. Progression of a stage A cancer seems more likely to result from PZ cancer than TZ cancer, and the finding of PZ cancer in a TURP specimen should probably preclude its classification as stage A1.

Entities:  

Mesh:

Year:  1991        PMID: 1747726     DOI: 10.1111/j.1464-410x.1991.tb15394.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  11 in total

1.  Heterogeneity of DNA methylation in multifocal prostate cancer.

Authors:  Inga Serenaite; Kristina Daniunaite; Feliksas Jankevicius; Arvydas Laurinavicius; Donatas Petroska; Juozas R Lazutka; Sonata Jarmalaite
Journal:  Virchows Arch       Date:  2014-11-05       Impact factor: 4.064

Review 2.  ACP Broadsheet No 146: August 1995. Macroscopic examination of prostatic specimens.

Authors:  P Harnden; M C Parkinson
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411

3.  A novel approach to the characterization of whole prostate pathology in glycol methacrylate.

Authors:  L E Monger; M Nagabhushan; T G Pretlow; T P Pretlow
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

4.  Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites.

Authors:  Monika Schmelz; Anne E Cress; Katherine M Scott; Friederike Bürger; Haiyan Cui; Karim Sallam; Kathy M McDaniel; Bruce L Dalkin; Raymond B Nagle
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

5.  Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.

Authors:  Aytekin Oto; Arda Kayhan; Yulei Jiang; Maria Tretiakova; Cheng Yang; Tatjana Antic; Farid Dahi; Arieh L Shalhav; Gregory Karczmar; Walter M Stadler
Journal:  Radiology       Date:  2010-09-15       Impact factor: 11.105

Review 6.  PI-RADS version 2.1 for the evaluation of transition zone lesions: a practical guide for radiologists.

Authors:  Caterina Gaudiano; Arianna Rustici; Beniamino Corcioni; Federica Ciccarese; Lorenzo Bianchi; Riccardo Schiavina; Francesca Giunchi; Michelangelo Fiorentino; Eugenio Brunocilla; Rita Golfieri
Journal:  Br J Radiol       Date:  2022-02-11       Impact factor: 3.039

7.  Do prostatic transition zone tumors have a distinct morphology?

Authors:  Joaquin J Garcia; Hikmat A Al-Ahmadie; Anuradha Gopalan; Satish K Tickoo; Peter T Scardino; Victor E Reuter; Samson W Fine
Journal:  Am J Surg Pathol       Date:  2008-11       Impact factor: 6.394

8.  TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry.

Authors:  Anuradha Gopalan; Margaret A Leversha; Maria E Dudas; Alexandra C Maschino; Jeremy Chang; Hikmat A Al-Ahmadie; Ying-Bei Chen; Satish K Tickoo; Victor E Reuter; Samson W Fine
Journal:  Histopathology       Date:  2013-05-23       Impact factor: 5.087

9.  A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53.

Authors:  J Kim; M Roh; I Doubinskaia; G N Algarroba; I-E A Eltoum; S A Abdulkadir
Journal:  Oncogene       Date:  2011-06-20       Impact factor: 9.867

10.  Impact of a rectal and bladder preparation protocol on prostate cancer outcome in patients treated with external beam radiotherapy.

Authors:  A Maggio; D Gabriele; E Garibaldi; S Bresciani; E Delmastro; A Di Dia; A Miranti; M Poli; T Varetto; M Stasi; P Gabriele
Journal:  Strahlenther Onkol       Date:  2017-06-15       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.